Role of luteolin in overcoming Parkinson's disease

Biofactors. 2021 Mar;47(2):198-206. doi: 10.1002/biof.1706. Epub 2021 Jan 14.

Abstract

Parkinson's disease (PD) is the second most common neurodegenerative disorder affecting elderly people (>60 years old) worldwide. There is no permanent cure for the disease but the symptomatic relief can be obtained by using dopamine agonists besides L-dopa therapy. The longer use of the drugs is associated with several side effects. Hence, the researchers have made a considerable attention toward the development of neuroprotective agents from plants. A number of phytochemicals have been demonstrated for their protective effects in various in vitro, in vivo, and clinical studies. In this context, luteolin, a flavone which is present in fruits and vegetables has been attributed to a number of pharmacological properties including neuroprotective. The present review demonstrates the bioavailability, oral absorption, and mechanism of action against PD.

Keywords: Parkinson's disease; bioavailability; luteolin; oxidative stress.

Publication types

  • Review

MeSH terms

  • Humans
  • Luteolin / pharmacology*
  • Neuroprotective Agents / pharmacology*
  • Parkinson Disease / drug therapy*
  • Phytochemicals / pharmacology*

Substances

  • Neuroprotective Agents
  • Phytochemicals
  • Luteolin